Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L E Friberg

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|December 20, 2013
Pharmacometrics and Systems Pharmacology Software Tutorials and Use: Comments and Guidelines for PSP ContributionsP Vicini, L E Friberg, P H van der Graaf, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 2, 2017
Item Response Theory to Quantify Longitudinal Placebo and Paliperidone Effects on PANSS Scores in SchizophreniaEhj Krekels, A M Novakovic, A M Vermeulen, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 6, 2017
Pharmacometric Modeling of Liver Metastases' Diameter, Volume, and Density and Their Relation to Clinical Outcome in Imatinib-Treated Patients With Gastrointestinal Stromal TumorsE Schindler, S M Krishnan, Rhj Mathijssen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 13, 2017
Semi-mechanistic pharmacokinetic-pharmacodynamic modelling of antibiotic drug combinationsM J E Brill, A N Kristoffersson, C Zhao, et al.
Advanced Drug Delivery Reviews|August 19, 2024
Model-informed precision dosing: State of the art and future perspectivesI K Minichmayr, E Dreesen, M Centanni, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 10, 2013
Pharmacokinetic-pharmacodynamic modeling of severity levels of extrapyramidal side effects with markov elementsV Pilla Reddy, K J Petersson, A A Suleiman, et al.
Cancer Chemotherapy and Pharmacology|January 4, 2001
Determination of drug effect on tumour cells, host animal toxicity and drug pharmacokinetics in a hollow-fibre model in ratsE Jonsson, L E Friberg, M O Karlsson, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 1, 2020
Evaluation of polymyxin B in combination with 13 other antibiotics against carbapenemase-producing Klebsiella pneumoniae in time-lapse microscopy and time-kill experimentsP Wistrand-Yuen, A Olsson, K-P Skarp, et al.
Clinical Pharmacology and Therapeutics|July 24, 2009
A pharmacodynamic Markov mixed-effects model for determining the effect of exposure to certolizumab pegol on the ACR20 score in patients with rheumatoid arthritisB D Lacroix, M R Lovern, A Stockis, et al.
Clinical Pharmacology and Therapeutics|July 17, 2009
The effect of decontamination procedures on the pharmacokinetics of venlafaxine in overdoseV V P Kumar, S Oscarsson, L E Friberg, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
CPT: Pharmacometrics & Systems Pharmacology|December 20, 2013
Pharmacometrics and Systems Pharmacology Software Tutorials and Use: Comments and Guidelines for PSP ContributionsP Vicini, L E Friberg, P H van der Graaf, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 2, 2017
Item Response Theory to Quantify Longitudinal Placebo and Paliperidone Effects on PANSS Scores in SchizophreniaEhj Krekels, A M Novakovic, A M Vermeulen, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 6, 2017
Pharmacometric Modeling of Liver Metastases' Diameter, Volume, and Density and Their Relation to Clinical Outcome in Imatinib-Treated Patients With Gastrointestinal Stromal TumorsE Schindler, S M Krishnan, Rhj Mathijssen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 13, 2017
Semi-mechanistic pharmacokinetic-pharmacodynamic modelling of antibiotic drug combinationsM J E Brill, A N Kristoffersson, C Zhao, et al.
Advanced Drug Delivery Reviews|August 19, 2024
Model-informed precision dosing: State of the art and future perspectivesI K Minichmayr, E Dreesen, M Centanni, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 10, 2013
Pharmacokinetic-pharmacodynamic modeling of severity levels of extrapyramidal side effects with markov elementsV Pilla Reddy, K J Petersson, A A Suleiman, et al.
Cancer Chemotherapy and Pharmacology|January 4, 2001
Determination of drug effect on tumour cells, host animal toxicity and drug pharmacokinetics in a hollow-fibre model in ratsE Jonsson, L E Friberg, M O Karlsson, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 1, 2020
Evaluation of polymyxin B in combination with 13 other antibiotics against carbapenemase-producing Klebsiella pneumoniae in time-lapse microscopy and time-kill experimentsP Wistrand-Yuen, A Olsson, K-P Skarp, et al.
Clinical Pharmacology and Therapeutics|July 24, 2009
A pharmacodynamic Markov mixed-effects model for determining the effect of exposure to certolizumab pegol on the ACR20 score in patients with rheumatoid arthritisB D Lacroix, M R Lovern, A Stockis, et al.
Clinical Pharmacology and Therapeutics|July 17, 2009
The effect of decontamination procedures on the pharmacokinetics of venlafaxine in overdoseV V P Kumar, S Oscarsson, L E Friberg, et al.
Pageof 4